InvestorsHub Logo
Followers 26
Posts 2868
Boards Moderated 0
Alias Born 12/05/2021

Re: flipper44 post# 430056

Tuesday, 12/28/2021 9:19:55 AM

Tuesday, December 28, 2021 9:19:55 AM

Post# of 700378
the challenge is not only the production capacity after approval the challenge is first and foremost getting all countries/insurances companies in a reasonable amount of time ready to reimburse approved DCVX L.

This is something that a Merck will be able to do blindfolded and NWBO has not even start to begin to think about thinking about.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News